Hepatorenal syndrome

被引:78
作者
Bataller, R [1 ]
Ginès, P [1 ]
Guevara, M [1 ]
Arroyo, V [1 ]
机构
[1] Univ Barcelona, Hosp Clin & Prov, Dept Med, Liver Unit, E-08036 Barcelona, Catalunya, Spain
关键词
cirrhosis; ascites; vasoactive systems;
D O I
10.1055/s-2007-1007201
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatorenal syndrome is a common complication in patients with advanced cirrhosis and ascites characterized not only by renal failure but also by marked alterations in systemic hemodynamics and vasoactive systems. Renal failure is due to a marked hypoperfusion of the kidney secondary to renal vasoconstriction. The pathogenesis of hepatorenal syndrome is not completely known but it is thought to be the extreme manifestation of the underfilling of the arterial circulation secondary to an arterial vasodilation, located mainly in the splanchnic circulation. Recently, a new definition and diagnostic criteria of hepatorenal syndrome have been proposed, which has stimulated research in this field Prognosis of patients with hepatorenal syndrome is very poor: Liver transplantation is the only effective treatment but it is not applicable in all patients due to short survival. New therapies developed during the last few years, such as the use of systemic vasoconstrictors or transjugular intrahepatic portosystemic shunts appear promising, but their usefulness should be evaluated in prospective investigations.
引用
收藏
页码:233 / 247
页数:15
相关论文
共 159 条
[1]   TREATMENT OF HEPATORENAL-SYNDROME WITH THE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) [J].
ALAM, I ;
BASS, NM ;
LABERGE, JM ;
RING, EJ ;
SOMBERG, KA .
GASTROENTEROLOGY, 1995, 108 (04) :A1024-A1024
[2]   CONTINUOUS PRAZOSIN ADMINISTRATION IN CIRRHOTIC-PATIENTS - EFFECTS ON PORTAL HEMODYNAMICS AND ON LIVER AND RENAL-FUNCTION [J].
ALBILLOS, A ;
LLEDO, JL ;
ROSSI, I ;
PEREZPARAMO, M ;
TABUENCA, MJ ;
BANARES, R ;
IBORRA, J ;
GARRIDO, A ;
ESCARTIN, P ;
BOSCH, J .
GASTROENTEROLOGY, 1995, 109 (04) :1257-1265
[3]  
ALVESTRAND A, 1984, LANCET, V1, P195
[4]   RENAL EFFECTS OF NATRIURETIC PEPTIDE RECEPTOR BLOCKADE IN CIRRHOTIC RATS WITH ASCITES [J].
ANGELI, P ;
JIMENEZ, W ;
ARROYO, V ;
MACKENZIE, HS ;
ZHANG, PL ;
CLARIA, J ;
RIVERA, F ;
BRENNER, BM ;
RODES, J .
HEPATOLOGY, 1994, 20 (04) :948-954
[5]   RENAL-FUNCTION IN CIRRHOSIS AND EFFECTS OF PROSTAGLANDIN-A1 [J].
ARIEFF, AI ;
CHIDSEY, CA .
AMERICAN JOURNAL OF MEDICINE, 1974, 56 (05) :695-703
[6]  
ARIYAN S, 1975, ANN SURG, V181, P847
[7]   Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [J].
Arroyo, V ;
Gines, P ;
Gerbes, AL ;
Dudley, FJ ;
Gentilini, P ;
Laffi, G ;
Reynolds, TB ;
RingLarsen, H ;
Scholmerich, J .
HEPATOLOGY, 1996, 23 (01) :164-176
[8]   RENAL-FUNCTION ABNORMALITIES, PROSTAGLANDINS, AND EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN CIRRHOSIS WITH ASCITES - AN OVERVIEW WITH EMPHASIS ON PATHOGENESIS [J].
ARROYO, V ;
GINES, P ;
RIMOLA, A ;
GAYA, J .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (2B) :104-122
[9]   EFFECT OF ANGIOTENSIN-II BLOCKADE ON SYSTEMIC AND HEPATIC HEMODYNAMICS AND ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN CIRRHOSIS WITH ASCITES [J].
ARROYO, V ;
BOSCH, J ;
MAURI, M ;
RIBERA, F ;
NAVARROLOPEZ, F ;
RODES, J .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1981, 11 (03) :221-229
[10]   SYMPATHETIC NERVOUS ACTIVITY, RENIN-ANGIOTENSIN SYSTEM AND RENAL EXCRETION OF PROSTAGLANDIN-E2 IN CIRRHOSIS - RELATIONSHIP TO FUNCTIONAL RENAL-FAILURE AND SODIUM AND WATER-EXCRETION [J].
ARROYO, V ;
PLANAS, R ;
GAYA, J ;
DEULOFEU, R ;
RIMOLA, A ;
PEREZAYUSO, RM ;
RIVERA, F ;
RODES, J .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1983, 13 (03) :271-278